Skip to main content

Year: 2020

STRATA Skin Sciences Reports Third Quarter 2020 Financial Results

HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2020.Recent HighlightsTotal revenue for the third quarter of 2020 was $5.6 million, a decrease of 25.0% over the third quarter of 2019–  Recurring revenue for the third quarter of 2020 was $3.8 million, a 35.9% decrease over the third quarter of 2019 and a 37.2% increase over the second quarter of 2020–  Gross domestic recurring billings were $4.7 million, a 155% increase over the second quarter 2020 (See Reconciliation of Non-GAAP measures below)Total gross margins in the third...

Continue reading

Xebec Announces Q3 2020 Financial Results

– Revenue of $18.4 million, negative EBITDA of $1.3 million and net loss of $2.2 million –MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of renewable gas solutions announced today its 2020 third quarter and nine-month period results, with the following highlights:Revenues of $18.4 million in the third quarter of 2020 compared to $13.2 million for the same period in 2019, a 39% increase.Negative EBITDA of $1.3 million for the third quarter of 2020 compared to positive EBITDA of $1.4 million for the same period in 2019.Net loss of ($2.2) million or ($0.02)/share for the third quarter of 2020, compared to a net profit of $1.0 million or $0.02/share for the same period in 2019.Working capital increased to $81.3 million on September 30, 2020, for a current...

Continue reading

Xebec annonce ses résultats financiers du 3e trimestre 2020

– Revenus de 18,4 $M, BAIIA négatif de 1,3 $M et perte nette de 2,2 $M –MONTRÉAL, 10 nov. 2020 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (« Xebec »), fournisseur mondial de solutions d’énergie propre, a annoncé aujourd’hui ses résultats du troisième trimestre 2020 et de la période des neuf premiers mois de 2020 avec les faits saillants suivants :Revenus de 18,4 M$ pour le troisième trimestre 2020 comparativement à 13,2 M$ pour la même période en 2019, ce qui correspond à une augmentation de 39 %.,Un BAIIA négatif de 1,3 M$ pour le troisième trimestre 2020, contre un BAIIA positif de 1,4 M$ pour la même période en 2019.Une perte nette de 2,2 M$ ou 0,02 $ par action pour le troisième trimestre 2020, comparativement à un profit net de 1,0 M$ ou 0,02 $ par action pour la période correspondante en 2019.Augmentation...

Continue reading

Middlefield Banc Corp. Announces 2020 Fourth Quarter Cash Dividend Payment

MIDDLEFIELD, Ohio, Nov. 10, 2020 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.15 per common share payable on December 15, 2020, to shareholders of record on December 4, 2020.Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.36 billion at September 30, 2020. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville. The Bank also operates a Loan Production Office in Mentor, Ohio.Additional information is available at www.middlefieldbank.bankThis...

Continue reading

Unibail-Rodamco-Westfield SE: Results of the Combined General Meeting of November 10, 2020

Paris, Amsterdam, November 10, 2020Press releaseUnibail-Rodamco-Westfield SE: Results of the Combined General Meeting of November 10, 2020Unibail-Rodamco-Westfield SE’s Combined General Meeting, held today at its registered office with a 59.34% quorum, voted upon six resolutions submitted to the vote of the shareholders, including three resolutions proposed by minority shareholders.Resolution #1: 61.62% of votes in favour. The resolution, delegating authority to the Management Board for the purpose of issuing ordinary shares of the Company with preferential subscription rights, is rejected as the two-thirds majority of the votes is not reached.Resolution a.: 63.26% of votes in favour. The appointment of Mr. Léon Bressler as member of the Supervisory Board is approved.Resolution b.: 59.16% of votes in favour. The appointment of Mrs. Susana...

Continue reading

Unibail-Rodamco-Westfield SE : Résultats de l’Assemblée Générale Mixte du 10 novembre 2020

Paris, Amsterdam, le 10 novembre 2020Communiqué de presseUnibail-Rodamco-Westfield SE : Résultats de l’Assemblée Générale Mixte du 10 novembre 2020L’Assemblée Générale Mixte des actionnaires d’Unibail-Rodamco-Westfield SE, qui s’est tenue ce jour au siège social avec un quorum de 59,34%, s’est prononcée sur six résolutions soumises au vote des actionnaires, dont trois proposées par des actionnaires minoritaires.Résolution N°1 : 61,62% de votes favorables. La résolution donnant délégation de compétence au Directoire à l’effet d’émettre des actions ordinaires de la Société avec maintien du droit préférentiel de souscription est rejetée, les deux tiers des votes étant nécessaires.Résolution a. : 63,26% de votes favorables. La nomination de M. Léon Bressler en qualité de membre du Conseil de surveillance est approuvée.Résolution b. : 59,16%...

Continue reading

Incontinence Care Products Market to Witness Remarkable Growth USD 24.35 billion by 2026; Increasing Geriatric Population and their Vulnerability to Incontinence Will Propel Growth, says Fortune Business Insights™

Pune, Nov. 10, 2020 (GLOBE NEWSWIRE) — The global incontinence care products market size is prophesized to reach a value of USD 24.35 billion by 2026, exhibiting a CAGR of 6.9% by 2026, between 2019 to 2026. This is attributable to the increasing geriatric population and the prevalence of incontinence problems among them. The market was valued at USD 14.30 billion in 2018. World Health Organization predicts about 120 million people in China will be above 80 years by the end of 2050. Such predictions will lead to surge in the number of patients with incontinence problems, thus propelling the incontinence care products market trends. Europe dominated the market with USD 4.94 billion earned in 2018. This is owing to the rise in demand for urinary catheters, coupled with the increasing demand for disposable incontinent devices.INDUSTRY...

Continue reading

Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Continued to enroll and dose patients in Phase 1/2 clinical trial of BDTX-189, with Phase 1 portion on track to complete by first half of 2021Strengthened Board of Directors with appointment of Robert A. Ingram as ChairmanBolstered executive team with appointment of Rachel Humphrey, M.D., as Chief Medical OfficerCash, cash equivalents, and investments of $333.1 million as of September 30, 2020, expected to be sufficient to fund operations into 2023CAMBRIDGE, Mass. and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today reported financial results for the third quarter ended September 30, 2020 and provided a corporate update.“At Black Diamond, we are leveraging our...

Continue reading

Population Health Management Market to Register an Excellent CAGR of 19.9% and Hit USD 91.43 Billion by 2026; Rising Shift from Fee-For-Service (FFS) to Aid Market Expansion, states Fortune Business Insights™

Pune, Nov. 10, 2020 (GLOBE NEWSWIRE) — The global population health management market size is predicted to reach USD 91.43 billion by 2026, exhibiting a CAGR of 19.9% during the forecast period. The market in North America generated a revenue of USD 13.84 billion in 2018 and is predicted to grow rapidly during the forecast period owing to the advanced healthcare infrastructure and greater adoption of healthcare IT.The rising shift from fee-for-service (FFS) to a value-based payment (VBP) in healthcare will have a positive impact on the Population Health Management Market growth during the forecast period. Moreover, the growing awareness regarding value-based payment (VBP) and its holistic approach, which allows clinical outcomes and reimbursement from insurance companies. Thus, the shift from conventional fee-for-service (FFS) reimbursement...

Continue reading

Medical Clothing Market to Exhibit 5.9% CAGR and Hit USD 99.9 Billion by 2027; Increasing Prevalence of Zoonotic Diseases to Drive Growth, says Fortune Business Insights™

Pune, Nov. 10, 2020 (GLOBE NEWSWIRE) — The global medical clothing market size is set to gain momentum from the rising incidence of hospital-acquired infections. Besides, the rising awareness campaigns regarding the benefits of clinical clothing would affect the market positively. The report further states that the medical clothing market size was USD 63.3 billion in 2019 and is projected to reach USD 99.9 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period. North America procured USD 25.5 billion in 2019 and is set to dominate in the forthcoming period. This growth is attributable to the presence of numerous medical clothing manufacturing companies, increasing prevalence of acute and chronic diseases, and developed healthcare infrastructure.KEY INDUSTRY DEVELOPMENTS:January 2020 – Cardinal Health announced that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.